The aim of the present study was to assess the efficacy of a ready-to-use injectable bone substitute on the prevention of alveolar ridge resorption after tooth extraction. Maxillary and mandibular premolars were extracted from 3 Beagle dogs with preservation of alveolar bone.
INTRODUCTION
Following tooth extraction, a blood clot develops into the socket and finally leads to newbone formation. [1] However, this healing process never allows an ad integrum restitution of the initial alveolar bone volume because a physiological resorption systematically conduct to a decrease of height and width of alveolar ridge. [2, 3] The resulting alveolar bone loss may generate difficulties to ensure long-term stability of conventional or implant-borne prosthetic restoration for partially or totally toothless patients. [4] Therefore, various techniques have been proposed to limit alveolar bone loss, such as atraumatic extraction, [5] immediate postextraction removable prosthesis, [6] immediate placement of dental implant [7, 8] or immediate bone filling of extraction socket. [9] [10] [11] Among the numerous available filling materials used to prevent alveolar crest resorption, [12] [13] [14] allografts and xenografts have shown limits because they sometimes generate problems of supply and risks of crossed contamination. [15, 16] To overcome these limits, many synthetic bone substitutes were proposed among which biphasic calcium phosphates (BCP), associations of hydroxyapatite (HA) and beta-tricalcium phosphate (ß-TCP). [17, 18] Calcium phosphate offer a great potential for bone regeneration since they have chemical composition close to the biological apatite of bone tissues. [19] BCP is generally prepared as blocks, granules or powders and has already proven its efficiency as a bone substitution material in different human applications. [20] [21] [22] In addition, previous studies showed that the granulated form of calcium phosphate ceramics gives satisfactory results for alveolar bone regeneration. [23, 24] However, particles present difficulties for placement into exiguous sites such as dental sockets. In order to improve their handling, BCP granules have been associated to a high viscosity polymer solution to form a ready-to-use injectable bone substitute (IBS). [25] [26] [27] [28] Previous animal studies conducted in our laboratory have clearly demonstrated the biocompatibility and the osseoconductive properties of IBS. [29] [30] [31] In the present work, we investigated the biofonctionnality and the influence of IBS on alveolar ridge preservation after tooth extraction. A comparative histomorphometric study was performed on fresh extraction sockets. Distal sockets were filled by IBS. As a control, mesial sockets were left unfilled to observe a physiological healing process.
MATERIALS AND METHODS

Injectable bone substitute
The biomaterial used in this study was a composite combining an hydrophilic polymer in solution and a calcium phosphate mineral phase. [25, 28, 32, 33] 
Polymeric phase
The polymeric phase was a cellulose derivative (hydropxypropylmethylcellulose = HPMC Benecel® MP824, Aqualon, Rueil-Malmaison, France) provided as dry powder. A solution of 2% HPMC was prepared by dissolving raw dry HPMC powder in sterile bi-distilled water under stirring for 3 days at 20°C.
Mineral phase
IBS mineral phase, composed of BCP granules with a 60/40 HA/ ß-TCP weight ratio, was obtained by alcaline hydrolysis of commercial dicalcium phosphate dihydrate. The resulting precipitated was dried to obtain a calcium deficient apatite powder. [34] Thereafter, this powder was humidified to realise a wet granulation (sifters 200-500 µm). Finally, powders have been transformed into ceramic after sintering at 1,150°C. BCP granulometry, alone and in association with HPMC, was controlled with a laser diffraction granulometer (LS230, Coulther, Miami, USA)
Composite : IBS
IBS was finally obtained by mixing the 2 % HPMC solution with BCP granules in a 50/50 weight ratio. Thereafter, IBS was put into ready-to-use injectors (Merck Eurolab, Fontenay-sous-Bois, France) (figure 1), and sterilised by steam at 121°C for 21 minutes (Kavoclave, Kavo, Warthausen, Germany). The diameter of the cannula was 2 mm. Before implantation, rheologic properties of IBS were controlled with viscosity analyser (DV-I+, Brookfield, Middleboro, USA) and texture analyser (TA TX2, Rheo, Champlan, France) .
Animal experiments
Surgical procedure
Three beagle dogs were used for animal experiments. They were 4-year old and respectively Antibiotic treatment (cephalosporin, 30 mg/kg/j) was continued for 48 hours after surgery by intramuscular injection. Animals were checked daily and soft consistency diet was given for 15 days. Sutures were removed 3 weeks after implantation. Then, a normal diet and an every two-days control were performed till sacrifice. Animals were sacrificed 13 weeks after implantation by intravenous injection (15 ml) of overdosed sodium pentobarbital (Dolethal, Vetoquinol laboratory, Lure, France).
Sample preparation
After sacrifice, mandibular and maxillary explants were immediately dissected and fixed in 4 % paraformaldehyde solution. Sockets were individually separated with a diamond saw. Samples were dehydrated in graded ethanol (80°, 95°, 100° at 4°C) during 3 days and placed in pure acetone for 24 hours at 4°C. Thereafter, two 8-days embeddments were performed in glycolmethylmethacrylate resin (GMMA) at -20°C. Finally, inclusions were performed in GMMA (4 days at + 4°C).
Histological evaluation
GMMA resin blocks samples were cut on a frontal level with a hard tissue microtome Thereafter, image analysis allowed to measure the mean heights (MeH) and the maximal heights 
RESULTS
Biomaterial characterization
IBS granulometry
Laser diffraction showed that BCP granules diameter ranged from 200 to 500 µm. This class of particles represents 78% of the total volume of BCP before incorporation in HPMC polymer, 70% in the composite before sterilisation, 66% in the composite after sterilisation, 65% in the composite at the beginning of injection and 64% in the composite at the end of the injection ( figure   4 ).
IBS rheologic properties.
The composite viscosity was 1,950,000 mPa.s. and a strength ranging from 200 to 600g was necessary to inject IBS ( figure 5 ). This force allows a not forced injection of the product which remains homogeneous for displacements of the piston lower than 15 mm. For displacements of the piston higher than 15 mm, the force necessary to the biomaterial extrusion increases quickly to reach 5,6 kg (data not shown). Thereafter, injection becomes difficult then impossible with demixtion of composite.
Clinical results
Minor complications were observed during the surgery. One oro-antral fistula was observed.
In addition, 2 vestibular process and 4 dental roots were fractured. These 7 sockets (3 maxillary and 4 mandibular) were not retained for further study. No infectious complication happened during the postoperative phase. Sutures were removed after a 3 weeks healing period, without any gingival inflammation.
SEM evaluations
No BCP granules were found in unfilled sites indicating the absence of material migration from the filled sites to the control sites.
For all unfilled sockets, crest collapse was always observed. Alveolar crest presented a morphology forming a concavity with relation to the cortical tangent vector (S-). No mineral component was detected between alveolar crest and vector ( figure 3a and 3b) .
In filled sockets, results were different for maxillary and mandibular sites. In filled and unfilled maxillary sockets, slight collapse crest has been systematically observed, but the bone loss appeared less important with IBS. In most of filled mandibular sockets, crest contour presented a convexity with respect to the vector.
Quantitative evaluation
In unfilled sites, there is no significant difference of mean (MeH) and maximal (MxH) height values between maxillary and mandibular sites ( figure 6 
DISCUSSION
In the present work, we have shown for the first time that an injectable biomaterial, composed of a biphasic calcium phosphate and a cellulose derivative polymer, could prevent alveolar crest resorption after tooth extraction.
Systematic filling of a non-damaged extraction socket is not justified because dental surgeons agree that the physiologic blood clot is one of the best healing material. [1] Nevertheless, after trauma or destructive periodontal disease, and in cases of thin alveolar bony-walls with high sensibility to postextractional resorption, this physiological healing process improved difficulties to support conventional or implant-supported prosthetic restoration. [35, 36] Furthermore, aesthetic and functional requirements from the patients are more and more important and can not be fulfilled without a sufficient bone volume. [37] To prevent the alveolar bone crest resorption, numerous filling biomaterials have been used among which calcium phosphate ceramics: hydroxyapatite (HA) and beta-tricalcium phosphate (ß-TCP) which have respectively shown variable results. [38] [39] [40] To improve HA and ß-TCP physicochemical properties, biphasic calcium phosphate (BCP), an HA/ß-TCP association, were secondly proposed. [19] When HA, ß-TCP or BCP were used for alveolar filling, the best resorption/substitution process were reported with granulated form. [23, 24] To overcome the manipulation limits of particles into exiguous tooth sockets, we have recently proposed toassociate BCP granules with a polymer solution to provide a ready-to-use injectable bone substitute (IBS). [25, 26, 28] . The osteoconductive potential of this innovative biomaterial was previously demonstrated for clinical application in our laboratory [29] [30] and in the same animal model [31] with the quantification of each component, BCP, bone and soft tissue. In an attempt to prevent the bone crest resorption after tooth extraction, the present study investigates the efficiency of IBS to promote the preservation of the alveolar ridge morphology after filling of fresh extraction sockets.
In a first set of experiments, we sought to confirm whether IBS exhibit handling properties compatible with its clinical potential applications as a socket filling material. Controls performed before implantation confirmed that IBS presents rheologic properties allowing to obtain a homogeneous filling of dental sockets. Injection from the bottom to the top of the socket did not reveal any difficulties. However, the limit in the increase of granule size is the preservation of IBS rheologic properties and the 200 to 500 µm particles seems to be the higher diameter appropriate to alveolar filling. The homogenisation triggers a reduction of 8 % of calcium phosphate mean size particles. However, BCP granulometry in the final product remains in the range of 200-500 µm. To strengthen our preliminary data, we are currently conducting studies on IBS with 40 to 80 µm and 80 to 200 µm diameter BCP granules.
The main objective of this work was to obtain quantitative results on alveolar bone crest resorption. Among the numerous available tools, we choosed the semi-automatic image analysis because it allows to analyse quickly and accurately a large amount of informations. [30, 41] However, our quantitative data showed some limitations since they were carried out with respect to the vestibular and lingual process, which may have been subjected to a post-extraction resorption process. Consequently, previous studies carried out on the alveolar resorption after dental extraction generally start from a fixed point such as an adjacent tooth or a dental implant. [42] [43] [44] [45] Nevertheless, this work highlights the clinical benefice provided by IBS. Most of the previous filling studies performed on Beagle dogs [46] [47] [48] have only used mandibular sockets, because of the extreme difficulty to atraumatically extracted maxillary teeth. In the present work, six mandibular premolar teeth and four maxillary premolar teeth were used for each animal to increase the available sockets for statistical analysis. Nevertheless, the study of the superior and inferior sockets was voluntarily separated in order to evaluate a potential difference between these two sites. To our knowledge, no documented research exists to explain our higher results obtained with mandibular sockets. Among the explaining causes are: (i) a larger cortical thickness to the mandible, (ii) a major quantity of injected material in mandibular sites and finally, (iii) a greater difficulty to carry out histological sections in the maxillary.
In the filled mandibular sockets, analysis of components of S+ has shown that nonmineralised areas occupied the half surface of the crest height gain. Two hypothesis can be assumed on the future of S+. First of all, since non-mineralised areas are located at the periphery of BCP and newly-formed bone, one can think that after BCP substitution, bone healing process will lead to the reduction of these non-mineralised areas. One can also assume that BCP and newly-formed bone only help on a temporary time the convex crest morphology maintenance. Secondary resorption would then be only delayed. Between both hypothesis, it is wise to envisage an intermediary alternative for which alveolar filling would enable, not a height gain, but an absence of resorption after complete bone healing and BCP resorption/substitution process. This alternative would constitute an interesting overhang for conventional or implant-borne prosthetic rehabilitations.
However, this hypothesis is to be confirmed by further experimentations over longer periods.
CONCLUSION
This study demonstrates that a composite biomaterial prevents alveolar crest resorption after 
